ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Tempero, Johnson Take ASCO Offices

June 6, 2003

McGivney Out at NCCN as Board Cites Management Style, Strategic Direction

January 13, 2012

In Brief: Li, Gart Retire Forom NCI; Clifford Heads Diet Branch; ASTRO Meeting Nov. 4-8 In Washington

October 18, 1991

Straus asks to “Set Record Straight”

September 2, 1988

ASCO Survey Finds Practice Expenses 90% Higher Than Medicare Assumptions

October 11, 2002

Vasectomy Doesn’t Increase Prostate Cancer Risk

July 26, 2002